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Background: Cognitive disorders associated with aging have been successfully managed by African traditional 
medical practitioners using various plants. This study evaluated the cognitive enhancing potentials of Morinda lucida 
(L) Rubiaceae and Peltophorum pterocarpum (DC) ex. K Heyne in scopolamine induced amnesic animals.  
Materials and Methods: The anti-amnesic activity of the ethyl acetate extracts of Morinda lucida and Peltophorum 
pterocarpum at doses of 4 mg/kg, 6 mg/kg and 8 mg/kg were assessed in scopolamine induced amnesic mice using 
Morris water maze test model. Effect of the extracts on the histology of the hippocampus was also evaluated. 
Results: The ethyl acetate extract of Morinda lucida and Peltophorum pterocarpum ameliorated scopolamine induced 
memory deficit in the animals under study. There was no effect of the extract on the histology of the hippocampus. 
However, there was an increase in the density of cells in the hippocampus of treated group as compared to the 
untreated. 
Conclusion: Morinda lucida and Peltophorum pterocarpum showed considerable enhancement of cognition in 
scopolamine induced amnesic mice. 
 





There is usually a decline in memory and the rate of information processing as a person grows older (Buckner, 
2004., Lesne et al., 2006). Like the body’s muscles, bones and other vital organs, the brain also feels the effect of aging 
(Sack et al., 2009). Through years of constant use and biological wear and tear, the brain gradually loses some of its 
sharpness in processing information and in relaying the multitude of signals that are essential for day to day functioning 
(Sack et al., 2009). However, age related memory loss does not indicate diminished intelligence or ability to learn 
(Friedman et al., 2006). The brain may sometimes need more time to recall information from memory or to learn new 
information. Therefore, simple forgetfulness is not a disease. 
A decline in cognitive functions has however been linked with several conditions such as neurodegenerative 
diseases like Alzheimer’s disease (AD) (Lesne et al., 2006) and as such is being clinically treated. Due to several 
limitations such as toxicity, short half-life and high cost (Giacobini, 2004) associated with some of these clinically 
available therapies, researchers are still working at getting better and cheaper alternatives especially from natural 
sources. 
Memory and learning impairment is the most characteristic manifestation of dementia (Lee et al., 2009) and 
this can be chemically induced in experimental animal with the injection of scopolamine, a cholinergic antagonist 
which interferes with acetylcholine (ACh) transmission in the central nervous system (Misane and Ogren 2003). 
Moreover, scopolamine induced amnesic animal model have been used widely in screening for compounds with 
therapeutic potential as anti-dementia (Lee et al., 2009, Rubaj et al., 2003). Also, Morris water maze test is widely 
accepted for the assessment of spatial memory in experimental animal model (Lee et al., 2009, Moris, 1984, Kin et al., 
2003).  
In Nigeria, ethno-medicine memory loss is taken seriously particularly by the youths who seek memory 
enhancing remedies to increase their ability to pass examinations. The old people also take such remedies as memory 
enhancers and anti-aging to alleviate suffering associated with old age (Elufioye et al., 2013). Peltophorum 
pterocarpum (DC) ex. K Heyne and Morinda lucida (L) Rubiaceae are commonly found in recipes used as memory 
enhancer or anti-aging in Nigeria ethno-medicine. The leaves of these plants have been previously reported to inhibit 
cholinesterase (Elufioye et al., 2010., Sridharamurthy et al., 2012) an enzyme that causes a decline of ACh in the brain 
by breaking it down. Acetylcholine is critical for an adequately functioning memory and it is the subject of the major 
researches for treatment of memory defects like those found in Alzheimer’s disease. Any mutual health issue that 
involves memory or lack of it is directly related to acetylcholine (Gais and Born, 2004). A major attempt to the 
treatment of Alzheimer’s disease has involved attempts to augment the cholinergic function of the brain (Auld et al., 
2002).  




This study is, therefore, aimed at evaluating the in vivo cognitive enhancing potential of extracts Peltophorum 
pterocarpum and Morinda lucida in scopolamine induced animal model using Morris water maze test. 
 
Materials and Methods 
Plants Collection and extraction 
 
Leaves of M. lucida and P. peltophorum were collected at the University of Ibadan in October 2014. The 
plants were authenticated at the Department of Pharmacognosy herbarium University of Ibadan with DPHUI NO; 1451 
for Morinda lucida and DPHUI NO; 1453 for Peltophorum pterocarpum. Approximately 1 g of fresh leaves of P. 
peltophorum and M. lucida were air dried for two weeks before oven drying at 40oC for 2 hours, powdered and stored 





Thirty-five albino mice were purchased from Institute of Advance Medical Research and Training (IMRAT), 
College of medicine, University of Ibadan.  
 
Administration of doses for the various groups 
 
The mice were weighed, labeled and grouped into seven groups of 5 animals each after which all animals were 
pre-injected intraperitoneally with 3 mg/kg scopolamine. Groups 1-3 were administered 0.2 ml equivalent doses of 4 
mg/kg, 6 mg/kg and 8 mg/kg of the extract of Morinda lucida while groups 4-6 were given same doses of Peltophorum 
pterocarpum extract and group 7 was given 0.2 ml of distilled water (negative control) for 3 consecutive days.  
 
Morris Water Maze Test Procedure 
 
This test is usually done to assess the spatial memory function. It was performed according to the method of 
Morris, 1984 with slight modifications according to Kim et al., 2003 and Lee et al., 2009. 
The water maze is a circular pool (90 cm in diameter and 45 cm in height) filled with water mixed with 157 mL of 
evaporated milk to a height of 30 cm. The pool was divided into four equal quadrants and a platform submerged below 
water level in one of the quadrants at 1 cm such that it was not visible from the surface. 
On day 1 of the experiment, the animals were trained to swim for 60 sec. in the absence of the platform. Subsequently, 
the animals were given two swimming trial sessions each day with the platform in place for four days. Their locations 
from start position to the platform was monitored, the escape latencies of each animal were measured with a stop watch 
and an average calculated for each trial session. Each mouse was allowed a period of 10 sec. on the platform after 
locating it. However, any animal which could not locate the platform after 120 sec. was also placed on the platform for 
10 sec and then removed from the pool. 
The time interval of 30 min was observed between daily trials. While the point of entry into the pool for the 
animals and the location of the platform remained unchanged between daily trials, it was changed on a daily basis. 
Changes in the escape latency from day-to-day stands for long term or reference memory, while changes from trial 1 to 
trial 2 on the same day represent working or short-term memory. 
Five mice were used per treatment and control group. Amnesia was induced in all animals by intra-peritoneal 
injection of 3 mg/kg scopolamine dissolved in water/DMSO. All animals were assessed for spatial memory 24 hours 
after the administration of scopolamine to establish amnesia. Treatment with different doses (0.2 mL of 4 mg/kg, 6 
mg/kg and 8mg/kg) of M. lucida and P. peltophorum extracts commenced after establishing amnesia in the animals. 




All the animals were sacrificed by cervical dislocation at the end of the experiments with their brains removed 
and preserved in phosphate formalin buffer for histopathological studies. Slides of the forebrain and hippocampus were 
prepared and observed under light microscope. Photomicrographs were taken, the number of cells per area in the CA1 
region of the hippocampus was estimated and density of each slide was calculated as follows: 
All area values were multiplied by a constant value of 0.088899 
Density = Number of cells  
                Area× 0.088899 
 
 




Results and Discussion 
 
 Impairment of memory and learning, the most characteristic manifestation of cognitive dysfunction can be 
induced chemically in people (Broks et al., 1988) as well as in experimental animals by scopolamine, a cholinergic 
antagonist known to interfere with acetylcholine transmission in the central nervous system (Misane and Ogren 2003). 
Herbal and traditional medicine which has been a major aspect of socio cultural heritage in Africa for hundred years 
(Okigbo and Mmeka, 2006) has successfully managed memory impairment with the use of memory enhancing and 
anti-aging herbs.  
 The effect of Morinda lucida and Peltophorum pterocarpum (two plants commonly included in recipes for 
memory enhancing) on scopolamine-induced memory deficit was evaluated using Morris water maze test. Morris water 
maze evaluates spatial, working and reference memory (Lee et al., 2009). 
In this study, the escape latency time in animals induced by scopolamine was significantly reduced by ethyl acetate 
extracts of both Morinda lucida and Peltophorum pterocarpum when compared with the control group that received 
distilled water, as shown in figures 1and 2. 
 
 




Figure 2: Effect of Peltophorum pterocarpum on scopolamine induced memory impairment mice in Morris  
Water maze test. 
 It was observed that Morinda lucida and Peltophorum pterocarpum improved the memory of the animals in 
a dose dependent manner. Animals administered with 4 mg/kg, 6 mg/kg and 8 mg/kg responded to the ethyl acetate 
extracts as they exhibited a reduction in escape latency times from Day 1, Day 2 and Day 3. The escape latencies as 




depicted in table 1 and table 2 showed a significant decrease to the ethyl acetate extracts of Morinda lucida and 
Peltophorum pterocarpum while the scopolamine treated group exhibited a characteristic swimming behavior 
consisting of circling around the pool and longer escape latency indicating impairment of their spatial memory. 
 
Table 1: Effects of M. lucida extract on scopolamine induces memory impairment in mice showing mean escape 
latency 
 Doses  Mean escape latency (+ SEM) 
4 mg/kg 25.11±3.89 
6 mg/kg 23.83±9.09 
8 mg/kg 23.33±4.33 
Scopolamine 47.33± 21.85 
 
 
Table 2: Effects of P. pterocarpum extract on scopolamine induces memory impairment in mice showing mean escape 
latency 
Doses  Mean escape latency (+ SEM) 
4 mg/kg 20.37±8.4 
6 mg/kg 24.30±6.95 
8 mg/kg 14.60±1.55 
Scopolamine 47.33± 21.85 
 
 The extracts showed dose-dependent cognitive enhancing activity with Peltophorum pterocarpum having 
shorter escape latency time of 14.60 + 1.55 at 8 mg/kg and thus appears to have better cognitive enhancing ability when 
compared with Morinda lucida with escape latency of 23.33 + 4.33 at the same dose.  
The cognitive enhancing activity observed in this study can be due to previously reported cholinesterase inhibitory 
property of these plants (Elufioye et al., 2010) since acetyl cholinesterase inhibitors are known to counteract 
scopolamine induced amnesia (Lee et al., 2009). This is probably because the effects of scopolamine in learning and 
memory are also mediated by cholinergic neurons in the ventral forebrain, particularly in those arising from the medial 
septal nuclei or the diagonal band of Broca and projecting to the hippocampus (Bejar et al., 1999).  
In the histopathology study, there was no significant change in the histology of the brain. However, it was observed that 
there was a reduction in density of cells in the hippocampus of the control mice pretreated with scopolamine who 
received only distilled water. However, there was an increase in the number and density of cells in the animals tested 
with extracts of Morinda lucida and Peltophorum pterocarpum (tables 3 and 4). The resultant increase may signify 
cognitive enhancement.  
 
Table 3: Result of the Histopathology studies on the Hippocampus of mice treated with Morinda lucida extract 
showing the cell count per area counted and density 
Doses (mg/kg) Cells counted per 
area  
Area (Square meter) Density 
4mg/kg 75 662400.00 0.001238 
6mg/kg 33 294100.00 0.001262 
8mg/kg 25 2029500.00 0.0001386 
Scopolamine (3mg/kg) 35 456875.00 0.000086813 
 
Table 4: Result of the Histopathology studies on the Hippocampus of mice treated with Peltophorum pterocarpum 
extract showing the cell count per area counted and density. 
Doses (mg/kg) Cells counted per unit area Area (Squmetre) Density 
4mg/kg 61 402500.00 0.001705 
6mg/kg 33 297118.80 0.001249 
8mg/kg 45 463137.50 0.001093 
Scopolamine (3mg/kg) 35 456875.00 0.000086813 
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Figure 5: Histopathology of the hippocampus of mice pretreated with 3 mg/kg Scopolamine Morinda lucida and 
Peltophorum pterocarpum at doses of 4 mg/kg, 6 mg/kg and 8 mg/kg exhibited significant gradual improvement in 




 The ethyl acetate extracts of Morinda lucida and Peltophorum pterocarpum possess significant cognitive- 
enhancing activity based on the results of the Morris water maze and histopathology studies of the hippocampus, and 
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